Apellis Pharmaceuticals Inc Earnings logo

APLS

Apellis Pharmaceuticals Inc Earnings

$18.27

Earnings Summary

Revenue
$166.8Mn
Net Profits
$-92.23Mn
Net Profit Margins
-55.29%
Highlights
Revenue:

Apellis Pharmaceuticals Inc’s revenue fell -3.21% since last year same period to $166.8Mn in the Q1 2025. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated -21.52% fall in its revenue since last 3-months.

Net Profits:

Apellis Pharmaceuticals Inc’s net profit fell -38.84% since last year same period to $-92.23Mn in the Q1 2025. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated -153.69% fall in its net profits since last 3-months.

Net Profit Margins:

Apellis Pharmaceuticals Inc’s net profit margin fell -43.45% since last year same period to -55.29% in the Q1 2025. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated -223.25% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Apellis Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter
-0.48
EPS Estimate Current Year
-0.48
Highlights
EPS Estimate Current Quarter:

Apellis Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.48 - a 12.02% jump from last quarter’s estimates.

EPS Estimate Current Year:

Apellis Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.48.

Key Ratios

Key ratios of the Apellis Pharmaceuticals Inc post its Q2 2025 earnings
Earning Per Share (EPS)
0
Highlights
Earning Per Share (EPS):

Apellis Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Apellis Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2025-08-11
-0.48
0
100%
2025-05-07
-0.54
-0.74
-37.04%